Churchill Capital Corp V (CCV) Signs Non-Binding LOI
by Nicholas Alan Clayton on 2022-12-16 at 9:11am

Churchill Capital Corp V (NYSE:CCV) announced in an 8-K filing this morning that it has signed a non-binding letter of intent (LOI) to combine with a target company and will be extending its transaction deadline to March 18, 2023.

The filing gave no other hints about the target other than it is a “private company that meets the Company’s investment criteria and principles and with which the Company has had discussions over an extended period of time.”

Churchill V’s announcement cuts it close to the SPAC’s transaction deadline, which was coming up on Sunday, December 18 and it had not scheduled an extension vote. But, it automatically gains three months more on its clock with an LOI in hand under the terms of its prospectus.

The SPAC also announced that it would be holding its trust purely in cash rather than government securities or money market funds moving forward. This is done to avoid any risk that the SPAC might be classified as an unregistered investment company, which is still up for debate in the pending new SEC SPAC rule.

Other teams have made this change as well, including the recently liquidated Austerlitz I & II. In practical terms, it means that Churchill V will generate no further interest.

The Churchill team has two other SPACs currently searching without a definitive agreement in hand: CVII and CCVI. But these each have an extra two months with deadlines coming up on February 16, 2023.

Nonetheless, there has been a question about the future of this prominent SPAC team’s remaining vehicles since it was announced that Michael Klein, serial SPAC sponsor and both CEO and chairman of all three, was stepping up to lead Credit Suisse’s (NYSE:CS) spin-off CS Boston.

The answer is that Klein is still in the SPAC game for now, and he has given himself a bit more time to make a firm decision.

 

Recent Posts
by Nicholas Alan Clayton on 2024-07-24 at 4:38pm

Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...

by Nicholas Alan Clayton on 2024-07-24 at 1:19pm

FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...

by Nicholas Alan Clayton on 2024-07-24 at 8:19am

At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...

by Nicholas Alan Clayton on 2024-07-23 at 4:33pm

Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...

by Nicholas Alan Clayton on 2024-07-23 at 1:00pm

Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved